Mercer Global Advisors
CRL icon

Mercer Global Advisors’s Charles River Laboratories CRL Stock Holding History

Mercer Global Advisors’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.6M Sell
7,075
-81
-1% -$14.4K ﹤0.01% 1473
2026
Q1 		$1.23M Buy
7,156
+840
+13% +$156K ﹤0.01% 1459
2025
Q4 		$1.26M Buy
6,316
+80
+1% +$14.5K ﹤0.01% 1334
2025
Q3 		$976K Buy
6,236
+3,223
+107% +$512K ﹤0.01% 1398
2025
Q2 		$457K Buy
3,013
+41
+1% +$5.47K ﹤0.01% 1609
2025
Q1 		$447K Buy
2,972
+521
+21% +$87.4K ﹤0.01% 1534
2024
Q4 		$452K Sell
2,451
-1,907
-44% -$367K ﹤0.01% 1504
2024
Q3 		$846K Buy
4,358
+327
+8% +$68K ﹤0.01% 1078
2024
Q2 		$833K Buy
4,031
+1,721
+75% +$390K ﹤0.01% 1052
2024
Q1 		$626K Buy
2,310
+210
+10% +$50.1K ﹤0.01% 1156
2023
Q4 		$497K Buy
2,100
+143
+7% +$28.1K ﹤0.01% 1333
2023
Q3 		$384K Buy
1,957
+287
+17% +$58.9K ﹤0.01% 1386
2023
Q2 		$351K Sell
1,670
-234
-12% -$46.6K ﹤0.01% 1414
2023
Q1 		$384K Buy
1,904
+230
+14% +$52.1K ﹤0.01% 1349
2022
Q4 		$365K Sell
1,674
-30
-2% -$6.55K ﹤0.01% 1390
2022
Q3 		$335K Sell
1,704
-77
-4% -$16.6K ﹤0.01% 1343
2022
Q2 		$381K Buy
1,781
+223
+14% +$54.5K ﹤0.01% 1297
2022
Q1 		$442K Sell
1,558
-1,248
-44% -$385K ﹤0.01% 1292
2021
Q4 		$1.06M Buy
2,806
+583
+26% +$227K 0.01% 858
2021
Q3 		$917K Sell
2,223
-18
-0.8% -$7.48K 0.01% 896
2021
Q2 		$829K Buy
2,241
+1,485
+196% +$496K 0.01% 918
2021
Q1 		$219K Buy
+756
New +$210K ﹤0.01% 1441

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Mercer Global Advisors's CRL Position: Q2 2026 in Review

Mercer Global Advisors reduced its Charles River Laboratories (CRL) stake by 1.1% in Q2 2026, selling an estimated $14.4K and leaving 7,075 shares worth $1.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1473.

Mercer Global Advisors first reported a position in CRL in Q1 2021 and has held it in 22 quarters since. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Mercer Global Advisors held 7,075 shares of Charles River Laboratories worth $1.6M as of Q2 2026.
  • Mercer Global Advisors sold 81 Charles River Laboratories shares in Q2 2026, an estimated $14.4K.
  • Charles River Laboratories made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #1473 holding.
  • Mercer Global Advisors first reported a position in Charles River Laboratories in Q1 2021 and has held it in 22 quarters since.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.